Home › Funds › DUPONT CAPITAL MANAGEMENT CORP › AEON
DUPONT CAPITAL MANAGEMENT CORP position in AEON
AEON BIOPHARMA INC · Health Care
DUPONT CAPITAL MANAGEMENT CORP reported holding 170 shares of AEON (AEON BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$51K, representing 0.00% of its reported portfolio and ranking #32 among its reported holdings. DUPONT CAPITAL MANAGEMENT CORP has disclosed AEON holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How DUPONT CAPITAL MANAGEMENT CORP's AEON position evolved
DUPONT CAPITAL MANAGEMENT CORP first disclosed a stake in AEON in Q3 2023 at 3 shares (US$0K). The position peaked in Q2 2026 at 170 shares, worth US$122K. Across 13 filings, DUPONT CAPITAL MANAGEMENT CORP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 170 shares valued at US$51K. Notable position changes include a 409300% increase in Q2 2024 (shares were roughly flat over the following quarter), a 99% trim in Q1 2025 (shares rose 31% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3 | $17 | New |
| Q4 2023 | 3 | $22 | Hold |
| Q1 2024 | 3 | $35 | Hold |
| Q2 2024 | 12.28K | $12.90K | Add |
| Q3 2024 | 12.28K | $12.90K | Hold |
| Q4 2024 | 12.28K | $6.63K | Hold |
| Q1 2025 | 170 | $99 | Reduce |
| Q2 2025 | 170 | $129 | Hold |
| Q3 2025 | 170 | $137 | Hold |
| Q4 2025 | 170 | $187 | Hold |
| Q1 2026 | 170 | $167 | Hold |
| Q2 2026 | 170 | $122.00K | Hold |
| Q3 2026 | 170 | $51.00K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AEON and 13F data
AEON (AEON BIOPHARMA INC) is a Health Care company. 20 other funds we track also report a position in AEON — the largest reported positions include Dauntless Investment Group, LLC (US$9.0M), DG Capital Management, LLC (US$78K), Beacon Wealthcare LLC (US$4K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AEON
- Dauntless Investment Group, LLC 12.49M sh · $8.98M · Q2 2026
- DG Capital Management, LLC 259.15K sh · $77.74K · Q3 2026
- Beacon Wealthcare LLC 12.86K sh · $3.86K · Q3 2026
More on DUPONT CAPITAL MANAGEMENT CORP
FAQ
How long has DUPONT CAPITAL MANAGEMENT CORP held AEON?
DUPONT CAPITAL MANAGEMENT CORP has disclosed AEON holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is DUPONT CAPITAL MANAGEMENT CORP's current position in AEON?
As of Q3 2026, DUPONT CAPITAL MANAGEMENT CORP holds 170 shares of AEON (AEON BIOPHARMA INC), valued at $51.00K, representing 0.00% of its reported portfolio and ranking #32.
Has DUPONT CAPITAL MANAGEMENT CORP been buying or selling AEON?
In the latest 13F filing (Q3 2026), DUPONT CAPITAL MANAGEMENT CORP held unchanged its position in AEON. The position peaked in Q2 2026 at 170 shares.
Which other funds hold AEON?
Other major institutional holders of AEON include Dauntless Investment Group, LLC, DG Capital Management, LLC, Beacon Wealthcare LLC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.